Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3350402)

Published in BMC Cancer on April 03, 2012

Authors

Erin J Aiello Bowles1, Heather Spencer Feigelson, Tom Barney, Katherine Broecker, Andrew Sterrett, Kimberly Bischoff, Jessica Engel, Gabrielle Gundersen, Johanna Sheehey-Jones, Richard Single, Adedayo Onitilo, Ted A James, Laurence E McCahill

Author Affiliations

1: Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA. bowles.e@ghc.org

Articles by these authors

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30

The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr (2013) 6.18

Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79

Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71

Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst (2004) 3.86

Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76

Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64

Variability in reexcision following breast conservation surgery. JAMA (2012) 3.26

A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08

Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst (2005) 2.86

Single- and multiple-dose pharmacokinetics of caspofungin in healthy men. Antimicrob Agents Chemother (2002) 2.68

Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol (2005) 2.51

Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45

Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev (2002) 2.45

Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21

Results of a national survey of surgical resident interest in international experience, electives, and volunteerism. J Am Coll Surg (2008) 2.10

Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg (2013) 2.08

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A (2009) 1.81

Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genet Med (2013) 1.55

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One (2008) 1.50

Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev (2005) 1.44

Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology (2013) 1.39

Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet Med (2012) 1.39

Young surgeons' attitudes regarding surgery and professional organizations. Am J Surg (2009) 1.38

Clinical outcomes using aggressive approach to anatomic screening and endovascular revascularization in a veterans affairs population with critical limb ischemia. Catheter Cardiovasc Interv (2009) 1.38

Getting to better cancer care: results of a society of surgical oncology survey. Ann Surg Oncol (2008) 1.37

Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res (2006) 1.37

Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons. Arch Surg (2009) 1.30

Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev (2008) 1.30

Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations. Philos Trans R Soc Lond B Biol Sci (2012) 1.28

The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women. Int J Cancer (2008) 1.24

Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.23

Biobanking for research: a survey of patient population attitudes and understanding. J Community Genet (2013) 1.20

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet (2010) 1.18

Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet (2011) 1.17

Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Hum Mol Genet (2010) 1.16

Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev (2012) 1.15

Troubleshooting video-assisted thoracic surgery lobectomy. Ann Thorac Surg (2005) 1.14

Arterioportal fistulas: introduction of a novel classification with therapeutic implications. J Gastrointest Surg (2006) 1.14

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis (2009) 1.13

Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype. Cancer (2009) 1.11

Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited. Clin Med Res (2007) 1.07

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res (2010) 1.06

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab (2010) 1.04

No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.03

Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy. Int J Cancer (2010) 1.02

Decision making in palliative surgery. J Am Coll Surg (2002) 1.01

Analysis of cohort studies with multivariate and partially observed disease classification data. Biometrika (2010) 1.01

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet (2009) 1.01

A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res (2005) 1.00

KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev (2012) 1.00

Risk factors for fatal breast cancer in African-American women and White women in a large US prospective cohort. Am J Epidemiol (2005) 1.00

Haplotypes of the estrogen receptor beta gene and breast cancer risk. Int J Cancer (2008) 0.99

Development of a quantitative PCR (TaqMan) assay for relative mitochondrial DNA copy number and the common mitochondrial DNA deletion in the rat. Environ Mol Mutagen (2004) 0.97

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Res (2006) 0.97

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev (2009) 0.97

Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization. J Genet Couns (2012) 0.94

Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum Mol Genet (2011) 0.94

Do behavioral smoking reduction approaches reach more or different smokers? Two studies; similar answers. Addict Behav (2005) 0.93

Full-thickness chest wall resection for recurrent breast carcinoma: an institutional review and meta-analysis. Am Surg (2005) 0.91

Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women. Cancer Causes Control (2011) 0.90

Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet (2011) 0.90

Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen. Int J Cancer (2010) 0.89

Are mastectomy rates a reasonable quality measure of breast cancer surgery? Am J Surg (2008) 0.88

When the sun can set on an unoperated bowel obstruction: management of malignant bowel obstruction. J Am Coll Surg (2002) 0.87

Concerns of family caregivers of patients with cancer facing palliative surgery for advanced malignancies. Oncol Nurs Forum (2003) 0.87

Hardy-Weinberg testing of a single homozygous genotype. Genetics (2005) 0.86

Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab (2014) 0.85

Quality measurement in cancer care delivery. Ann Surg Oncol (2011) 0.84

Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity. Breast Cancer Res Treat (2011) 0.83

Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome. BMC Res Notes (2014) 0.83

Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care (2012) 0.82

CYP17 genotype predicts serum hormone levels among pre-menopausal women. Hum Reprod (2005) 0.82

Should all duty hours be the same? Results of a national survey of surgical trainees. J Am Coll Surg (2009) 0.81

Premenopausal vasomotor symptoms in an ethnically diverse population. Menopause (2014) 0.81

Cryopreservation of whole blood samples collected in the field for a large epidemiologic study. Cancer Epidemiol Biomarkers Prev (2007) 0.81

Family history of various cancers and pancreatic cancer mortality in a large cohort. Cancer Causes Control (2009) 0.81

Local recurrence after partial mastectomy: relation to initial surgical margins. Am J Surg (2011) 0.80

Pancreatic Resection Results in a Statewide Surgical Collaborative. Ann Surg Oncol (2015) 0.79

Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis (2002) 0.79

Quality assessment of neoadjuvant therapy use in breast conservation: barriers to implementation. Breast J (2009) 0.79

Predicting life expectancy and symptom relief following surgery for advanced malignancy. Ann Surg Oncol (2008) 0.79

Sickle cell crisis associated with hemophagocytic lymphohistiocytosis. Am J Hematol (2004) 0.79

Variability in the quality of pathology reporting of margin status following breast cancer surgery. Ann Surg Oncol (2011) 0.78

Variant mastectomy rates: implications for quality of care in breast cancer surgery. J Clin Oncol (2010) 0.78

Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). BMC Cancer (2009) 0.78